This page explains Peptivex’s posture on safety, the limits of what we publish, and what to do if you have a concern about something on the Site.
1. Peptivex Is Not a Safety Authority
Peptivex summarizes the published research literature. It is not, and does not represent itself as, a safety monitoring body, an adverse-event reporting system, or a substitute for the regulatory agencies and licensed clinicians who actually evaluate safety for individual patients.
If you are deciding whether a compound is safe for you, the only appropriate path is a conversation with a qualified, licensed healthcare professional who knows your full medical history.
2. Regulatory Status Matters
Many compounds discussed on Peptivex are investigational, off-label relative to their approved use, or not approved by the U.S. Food and Drug Administration or any comparable authority for any human indication. The Site labels indication status on every compound and compound-condition page so readers can see this context at a glance.
Compounds that are not approved have, by definition, not completed the regulatory safety review required for marketing as a drug for human use. The absence of approval is itself a safety signal worth taking seriously.
3. What We Surface in Safety Sections
For every compound covered, we attempt to surface:
- Adverse events reported in clinical trials and case reports
- Known contraindications and cautions discussed in the literature
- Drug-drug, drug-condition, and population-specific considerations
- Pharmacovigilance signals from regulatory sources where available
- Negative, null, and mixed findings that complicate the safety picture
- Important gaps where safety data are absent or limited
We try to present this neutrally rather than reassuringly. A short adverse-event list is often a sign of limited study, not of safety.
4. What We Do Not Provide
Peptivex does not provide:
- Personalized risk assessments
- Guidance on whether a specific compound is safe for a specific person
- Dose-by-dose safety thresholds
- Reconstitution, sterility, or injection technique instructions
- Sourcing or product-quality assessments
- Reassurance about products from any vendor or pharmacy
Any AI features on the Site refuse requests in these categories.
5. Quality and Contamination Concerns
Compounds sold as “research chemicals” or sourced outside the licensed pharmaceutical supply chain can vary substantially in identity, purity, potency, and contamination profile. Peptivex does not evaluate, certify, or comment on the quality of any specific seller’s product. The absence of comment in either direction is not an endorsement.
6. Reporting an Adverse Event
Peptivex does not collect or process adverse-event reports. If you or someone you know has experienced an adverse event related to a medication or compound:
- United States: Report to the FDA MedWatch program at fda.gov/medwatch
- Other countries: Report to your national pharmacovigilance authority
- Medical emergency: Call 911 (U.S.) or your local emergency number immediately
7. Reporting a Content Concern
If you believe content on Peptivex is unsafe, misleading, materially incomplete, or otherwise raises a safety concern, please email peptivex@gmail.com with the subject line “Content Concern.”
Useful information to include:
- The URL of the page in question
- The specific claim or framing you are concerned about
- Any citations or evidence supporting your concern
- Whether you would like a response
We review good-faith content concerns and update content when warranted. We are not able to respond to every message, but we take safety-related concerns seriously.
8. Vulnerable Populations
The Site does not direct content to, and is not intended for use by:
- Anyone under 18 years of age
- Pregnant or breastfeeding individuals
- Individuals using the Site as a substitute for active clinical care
Compounds discussed in adult research contexts may pose distinct risks to children, pregnancy, lactation, and other vulnerable populations that are not always quantified in the published literature.
9. AI Output and Safety
Any AI features on Peptivex are constrained to:
- Summarize published research only
- Refuse dosing, sourcing, protocol, stack, injection, and personal-recommendation requests
- Include indication status and safety context in responses where relevant
- Disclose when evidence is limited, mixed, or absent
AI output can still be incomplete or wrong. AI output is not medical advice, is not a substitute for professional care, and should be cross-checked against cited sources before being relied on for any purpose.
10. Crisis Resources
Peptivex is a research-information site and is not equipped to respond to mental-health crises. If you are in crisis:
- United States: Call or text 988 (Suicide and Crisis Lifeline)
- International: Contact your local emergency services or a crisis line in your country
11. Contact
Safety concerns, content concerns, and questions:
Email: peptivex@gmail.com
Subject line for safety/content concerns:“Content Concern”